Chemokine-directed dendritic cell trafficking in allograft rejection

Current Opinion in Organ Transplantation

Volumn 8, Issue 1, 2003, Pages 35-39

  Hancock, Wayne W ^a,b   Wang, Liqing ^a   Ye, Qunrui ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344510736     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/00075200-200303000-00008     Document Type: Review

References (58)

1. Liu YJ: Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001, 106:259-262.
2. Mellman I, Steinman RM: Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106:255-258.
3. Shortman K, Liu YJ: Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
4. Penna G, Sozzani S, Adorini L: Selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 2001, 167:1862-1866.
5. Kucharzik T, Hudson JT, Waikel RL, et al.: CCR6 expression distinguishes mouse myeloid and lymphoid dendritic cell subsets: demonstration using a CCR6 EGFP knock-in mouse. Eur J Immunol 2002, 32:104-112.
6. Wang Y, Zhang Y, Yoneyama H, et al.: Identification of CD8α+CD11c- lineage phenotype-negative cells in the spleen as committed precursor of CD8α+ dendritic cells. Blood 2002, 100:569-577.
7. Merad M, Fong L, Bogenberger J, et al.: Differentiation of myeloid dendritic cells into CD8α-positive dendritic cells in vivo. Blood 2000, 96:1865-1872.
8. Randolph GJ: Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin Immunol 2001, 13:267-274.
9. Jakob T, Ring J, Udey MC: Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 2001, 108:688-696.
10. Yoshimura S, Bondeson J, Brennan FM, et al.: Role of NFκB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur J Immunol 2001, 31:1883-1893.
11. Baltathakis I, Alcantara O, Boldt DH: Expression of different NF-κB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling. J Cell Biochem 2001, 83:281-290.
12. Moschella F, Maffei A, Catanzaro RP, et al.: Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumor necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma. Br J Haematol 2001, 114:444-457.
13. Weih DS, Yilmaz ZB, Weih F: Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol 2001, 167:1909-1919.
14. Poljak L, Carlson L, Cunningham K, et al.: Distinct activities of p52/NF-κB required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3. J Immunol 1999, 163:6581-6588.
15. Xing N, L Maldonad M, Bachman L, et al.: Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem Biophys Res Commun 2002, 297:645.
16. Saikh KU, Khan AS, Kissner T, et al.: IL-15-induced conversion of monocytes to mature dendritic cells. Clin Exp Immunol 2001, 126:447-455.
17. Mohamadzadeh M, Berard F, Essert G, et al.: Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J Exp Med 2001, 194:1013-1020.
18. Munn DH, Sharma MD, Lee JR, et al.: Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002, 297:1867-1870.
19. Dhodapkar MV, Steinman RM, Krasovsky J, et al.: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001, 193:233-238.
20. Chen Z, Dehm S, Bonham K, et al.: DNA array and biologic characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy. Cell Immunol 2001, 214:60-71.
21. Barratt-Boyes SM, Zimmer MI, Harshyne LA, et al.: Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cellbased vaccines. J Immunol 2000, 164:2487-2495.
22. Bouchon A, Hernandez-Munain C, Cella M, et al.: A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 2001, 194:1111-1122.
23. Larsen CP, Morris PJ, Austyn JM: Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 1990, 171:307-314.
24. Larsen CP, Steinman RM, Witmer-Pack M, et al.: Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990, 172:1483-1493.
25. Saiki T, Ezaki T, Ogawa M, et al.: In vivo roles of donor and host dendritic cells in allogeneic immune response: cluster formation with host proliferating T cells. J Leukoc Biol 2001, 69:705-712.
26. Saiki T, Ezaki T, Ogawa M, et al.: Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 2001, 71:1806-1815.
27. Hirao M, Onai N, Hiroishi K, et al.:CCchemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Cancer Res 2000, 60:2209-2217.
28. Gallucci S, Lolkema M, Matzinger P: Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999, 5:1249-1255.
29. Moodycliffe AM, Shreedhar V, Ullrich SE, et al.: CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J Exp Med 2000, 191:2011-2020.
30. Bleharski JR, Niazi KR, Sieling PA, et al.: Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. J Immunol 2001, 167:3174-3181.
31. Hancock WW, Lu B, Gao W, et al.: Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000, 192:1515-1519.
32. Hancock WW, Gao W, Csizmadia V, et al.: Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001, 193:975-980.
33. Forster R, Schubel A, Breitfeld D, et al.: CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
34. Gunn MD, Kyuwa S, Tam C, et al.: Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999, 189:451-460.
35. Luther SA, Tang HL, Hyman PL, et al.: Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci U S A 2000, 97:12694-12699.
36. Mori S, Nakano H, Aritomi K, et al.: Mice lacking expression of the chemokines CCL 21-ser and CCL19 (plt mice) demonstrate delayed but enhanced t cellimmune responses. J Exp Med 2001, 193:207-217.
37. Forster R: FTY720 and lymphocyte trafficking. Nieren- und Hochdruckkrankheiten 2002, in press.
38. Wang L, King JA, Nakano H, et al.: Leukocyte trafficking to secondary lymphoid tissues is not required for allograft rejection but is required for tolerance induction. Am J Transplantation 2002, 2:223.
39. Varona R, Villares R, Carramolino L, et al.: CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed- type hypersensitivity responses. J Clin Invest 2001, 107:R37-45.
40. Colvin BL, Thomson AW. Chemokines, their receptors, and transplant outcome. Transplantation 2002, 74:149-155.
41. Larsen CP, Barker H, Morris PJ, et al.: Failure of mature dendritic cells of the host to migrate from the blood into cardiac or skin allografts. Transplantation 1990, 50:294-301.
42. Garcia-Lopez MA, Sanchez-Madrid F, Rodriguez-Frade JM, et al.: CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab Invest 2001, 81:409-418.
43. Fahy O, Porte H, Senechal S, et al.: Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin. Am J Pathol 2001, 158:1053-1063.
44. Takayama T, Morelli AE, Onai N, et al.: Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but downregulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability. J Immunol 2001, 166:7136-7143.
45. Brinkmann V, Pinschewer D, Chiba K, et al.: FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol Sci 2000, 21:49-52.
46. Mandala S, Hajdu R, Bergstrom J, et al.: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296:346-349.
47. Brinkmann V, Davis MD, Heise CE, et al.: The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002, 277:21453-21457.
48. Henning G, Ohl L, Junt T, et al.: CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med 2001, 194:1875-1881.
49. Woltman AM, Massacrier C, de Fijter JW, et al.: Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development. J Immunol 2002, 168:6181-6188.
50. Woltman AM, Van Der Kooij SW, Coffer PJ, et al.: Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells leading to apoptosis via increased p27KIP1 expression. Blood 2002.
51. Matsue H, Yang C, Matsue K, et al.: Contrasting impacts of immunosuppressive agents (Rapamycin, FK506, Cyclosporin A, and Dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation. J Immunol 2002, 169:3555-3564.
52. Morelli AE, Hackstein H, Thomson AW: Potential of tolerogenic dendritic cells for transplantation. Semin Immunol 2001, 13:323-335.
53. dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 1996, 62:659-665.
54. Rastellini C, Lu L, Ricordi C, et al.: Granulocyte/macrophage colonystimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995, 60:1366-1370.
55. Hayamizu K, Huie P, Sibley RK, et al.: Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation. Transplantation 1998, 66:1285-1291.
56. Lutz MB, Suri RM, Niimi M, et al.: Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000, 30:1813-1822.
57. O'Connell PJ, Li W, Wang Z, et al.: Immature and mature CD8α+ dendritic cells prolong the survival of vascularized heart allografts. J Immunol 2002, 168:143-154.
58. dim, B7-2-) induce alloantigenspecific hyporesponsiveness in murine T lymphocytes. Transplantation 1995, 60:1539-1545.